Staben Steven
SEC insider (Form 3/4/5 filer). CIK 0002159565. Chief Scientific Officer at Lycia Therapeutics, Inc. (LYCA). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in SOUTH SAN FRANCISCO, CA.
Companies Staben Steven has filed insider reports for
- Lycia Therapeutics, Inc. (LYCA): Officer, 10% Owner, Chief Scientific Officer
Staben Steven
CIK: 0002159565
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LYCA
Lycia Therapeutics, Inc.
Officer10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions